Ibritumomab tiuxetan 90y
- Level
- Commodity
- Parent
- 51441600
- Below
- 0
- Links · KBLI
- 10
Definition
UNSPSC 51441612This classification denotes an immunoconjugate, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 4Q52C550XK. The European Medicines Agency schedules Ibritumomab tiuxetan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20031. Ibritumomab tiuxetan generally arises in the molecular formula C23H32N5O10S. The term IBRITUMOMAB TIUXETAN is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, volume 14, no. 1, 2000, list 43.) SMILES: none.
Same parent
Under 51441600 · 11Activities that produce or sell this
KBLI · 10Inherited from family 51440000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.